No connection

Search Results

CCM vs JNJ

CCM
Concord Medical Services Holdings Limited
BEARISH
Price
$4.00
Market Cap
$17.4M
Sector
Healthcare
AI Confidence
95%
JNJ
Johnson & Johnson
NEUTRAL
Price
$237.96
Market Cap
$573.46B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
CCM
--
JNJ
21.55
Forward P/E
CCM
-26.67
JNJ
18.9
P/B Ratio
CCM
-0.05
JNJ
7.03
P/S Ratio
CCM
0.05
JNJ
6.09
EV/EBITDA
CCM
-22.79
JNJ
17.81

Profitability

Gross Margin
CCM
-11.44%
JNJ
68.08%
Operating Margin
CCM
-72.1%
JNJ
23.97%
Profit Margin
CCM
-44.6%
JNJ
28.46%
ROE
CCM
-29.03%
JNJ
35.03%
ROA
CCM
-4.48%
JNJ
8.68%

Growth

Revenue Growth
CCM
-8.3%
JNJ
9.1%
Earnings Growth
CCM
--
JNJ
48.6%

Financial Health

Debt/Equity
CCM
2.22
JNJ
0.6
Current Ratio
CCM
0.42
JNJ
1.03
Quick Ratio
CCM
0.1
JNJ
0.69

Dividends

Dividend Yield
CCM
--
JNJ
2.19%
Payout Ratio
CCM
0.0%
JNJ
46.6%

AI Verdict

CCM BEARISH

CCM exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis. The company suffers from negative gross margins (-11.44%), meaning it loses money on every unit of service provided before operating expenses are even considered. With a Price-to-Book ratio of -0.05, the company has negative shareholder equity, and a Quick Ratio of 0.10 indicates an inability to meet short-term obligations. Combined with declining revenue (-8.30% YoY) and a 5-year price collapse of 89%, the fundamental outlook is highly precarious.

Strengths
Extremely low Price-to-Sales ratio (0.05)
Recent short-term price recovery (+9.6% over 1 month)
Positive Q/Q EPS growth (+60.4%) though still negative in absolute terms
Risks
Negative Gross Margins indicating a fundamentally broken business model
Severe liquidity risk with a Current Ratio of 0.42 and Quick Ratio of 0.10
Negative Book Value (Price/Book -0.05) suggesting insolvency
JNJ NEUTRAL

JNJ presents a dichotomy between strong profitability and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the company maintains an impressive ROE of 35.03% and a consistent history of earnings beats, the current price of $237.96 trades at a significant premium to its Graham Number of $91.72. Growth remains robust on a YoY basis, but bearish insider sentiment and a very weak technical trend (10/100) suggest immediate headwinds. The stock is fundamentally sound in terms of earnings power but shows signs of operational inefficiency or declining quality in its deterministic health metrics.

Strengths
Exceptional Return on Equity (ROE) of 35.03%
Strong profit margins (28.46%) and gross margins (68.08%)
Consistent earnings beat track record over 25 quarters
Risks
Weak Piotroski F-Score (3/9) indicating declining fundamental health
Bearish insider activity with $58.35M in net sales and zero buys
Low liquidity indicated by a Quick Ratio of 0.69

Compare Another Pair

CCM vs JNJ: Head-to-Head Comparison

This page compares Concord Medical Services Holdings Limited (CCM) and Johnson & Johnson (JNJ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile